ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

174
Analysis
Health CareChina
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
18 Aug 2024 07:00

Last Week in Event SPACE: Aussie Tax Loss Basket, CK Infra, JTower, Porsche

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
319 Views
Share
17 Aug 2024 15:00

(Mostly) Asia-Pac M&A: TCM, BusinessOn Comm, Orora, Ramsay Health Care, Namoi Cotton, APM, CPMC

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
462 Views
Share
12 Aug 2024 00:33

Merger Arb Mondays (12 Aug) - China TCM, Canvest, GA Pack, Fuji Soft, Fancl, Descente, Takiron

This week, the highest gross spreads are HEC Pharma (112.5%), China TCM (27.1%), Canvest (11.4%), Malaysia Airports (10.1%), Asia Cement China...

Logo
368 Views
Share
bullishFuji Soft Inc
10 Aug 2024 15:00

(Mostly) Asia-Pac M&A: Fuji Soft, C.I. TAKIRON, Pacific Smiles, GaPack, Asia Cement, Shinko Electric

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
406 Views
Share
bullishAlps Logistics
06 Aug 2024 10:09

Go-To Arbs Amid Market Carnage

As global market roil, clean M&A deals come into focus. This insight briefly summarises those deals which are expected to comfortably complete,...

Logo
559 Views
Share
x